Cargando…

A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma

BACKGROUND: Preclinical studies suggest that interleukin-9 may be a central mediator in the development and maintenance of airway inflammation in asthma. The aim of this study was therefore to evaluate the effects of MEDI-528, an anti-interleukin-9 monoclonal antibody, in adults with confirmed uncon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Chad K, Leigh, Richard, McLaurin, Kimmie K, Kim, Keunpyo, Hultquist, Micki, Molfino, Nestor A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848834/ https://www.ncbi.nlm.nih.gov/pubmed/24050312 http://dx.doi.org/10.1186/1465-9921-14-93

Ejemplares similares

A meta-analysis of anti-interleukin-13 monoclonal antibodies for uncontrolled asthma
por: Li, Hang, et al.
Publicado: (2019)

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma
por: Parker, Joseph M, et al.
Publicado: (2011)

The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)

Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain
por: Casas-Maldonado, Francisco, et al.
Publicado: (2023)

Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes
por: McLaurin, Kimmie K., et al.
Publicado: (2015)

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)

Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma
por: Molfino, Nestor A, et al.
Publicado: (2016)

Hospitalizations in the First Year of Life for Infants with Respiratory Syncytial Virus and Unspecified Bronchiolitis in a Population-Based Cohort
por: Lee, Henry, et al.
Publicado: (2017)

A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
por: Agumadu, Vivian C, et al.
Publicado: (2018)

Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
por: Shahabi, Ahva, et al.
Publicado: (2017)

Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations
por: Bennett, Mihoko V., et al.
Publicado: (2018)

Repeated exacerbation of asthma: An intrinsic phenotype of uncontrolled asthma
por: Jain, Neeraj, et al.
Publicado: (2019)

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012
por: Doucette, Abigail, et al.
Publicado: (2016)

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
por: Pavilack, Melissa, et al.
Publicado: (2017)

A case of uncontrolled asthma
por: Aydin, Ömür, et al.
Publicado: (2011)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

National Bronchiolitis Hospitalization Rates Among Preterm and Full Term Infants: 2010–2015
por: Krilov, Leonard R, et al.
Publicado: (2017)

Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US
por: McLaurin, Kimmie K, et al.
Publicado: (2019)

Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
por: Douedi, Steven, et al.
Publicado: (2020)

Elevated Serum Interleukin-8 Level as a Preferable Biomarker for Identifying Uncontrolled Asthma and Glucocorticosteroid Responsiveness
por: Zhang, Jingxi, et al.
Publicado: (2017)

Laryngomalacia presenting as severe uncontrolled asthma
por: Tamura, Kanami, et al.
Publicado: (2018)

Monoclonal antibodies reactive with the mouse interleukin 5 receptor
Publicado: (1989)

Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
por: Parikh, Rohan C., et al.
Publicado: (2017)

Impact of Respiratory Syncytial Virus–Confirmed Hospitalizations on Caregivers of US Preterm Infants
por: Pokrzywinski, Robin M., et al.
Publicado: (2019)

Inhibition of murine B and T lymphopoiesis in vivo by an anti- interleukin 7 monoclonal antibody
Publicado: (1993)

Oxidative stress in patients with asthma and its relation to uncontrolled asthma
por: Ammar, Mariam, et al.
Publicado: (2022)

Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthma
por: Singh, Dave, et al.
Publicado: (2023)

Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data
por: Arend, Rebecca C., et al.
Publicado: (2021)

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer
por: Simmons, Daniel, et al.
Publicado: (2022)

A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma
por: Singh, Dave, et al.
Publicado: (2010)

PCSK9 Monoclonal Antibodies: An Overview
por: Kaddoura, Rasha, et al.
Publicado: (2020)

Targeting TSLP in Asthma
por: Parnes, Jane R, et al.
Publicado: (2022)

Langerhans Cell Histiocytosis Presenting as Uncontrolled Asthma
por: Rawlins, Frederic A., et al.
Publicado: (2013)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

What Will Uncontrolled Asthma Cost in the United States?
por: Nurmagambetov, Tursynbek A., et al.
Publicado: (2019)

Uncontrolled Asthma: Unmet Needs in the Management of Patients
por: Caminati, Marco, et al.
Publicado: (2021)

Contribution of allergy in the acquisition of uncontrolled severe asthma
por: Delgado Dolset, María Isabel, et al.
Publicado: (2022)

Glucocorticoid-Induced Cardiomyopathy Caused by Uncontrollable Asthma
por: Uehara, Hiroki, et al.
Publicado: (2023)

Monoclonal antibodies specific for interleukin 3-sensitive murine cells
Publicado: (1986)

A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
por: Piper, Edward, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_74deeppr45c3g164avamq8f08o